LATEST ALERTS
This report examines regulatory developments in cannabis consumption and explains why CannIntelligence believes that intoxicating cannabinoid beverages have a bright future in the US
This report aims to briefly analyse the most important legal developments of 2023 related to the EU sustainability proposals that are most likely to impact the CBD vape sector
Following our report earlier this year on IHDC online availability in Europe, this report identifies and examines any change in interest for these products from retailers and consumers in the third quarter of the year
US-based 22nd Century will sell its hemp/cannabis subsidiary, GVB Biopharma, to an entity affiliated with current GVB employees and will use the sale proceeds to pay off debt and further deleverage its balance sheet
Cannabinoids can be found in numerous plants, animals and fungi, and as more are unearthed and their properties tested, our knowledge of potential applications and uses expands
This report provides a detailed analysis of the current regulatory framework in place in Colombia for cannabis, hemp and other cannabinoids including CBD
US hemp farmers will be able to continue operating under the 2018 Farm Bill framework until the end of September next year, as stopgap funding was approved and signed into law by president Joe Biden
Japan may very soon ban hexahydrocannabihexol (HHCH) and other synthetic cannabinoid derivatives in the wake of the country’s first medical cannabis regulation bill passing its initial parliamentary scrutiny
Japan’s first medical cannabis law may end up only legalising a single pharmaceutical product, while also criminalising recreational cannabis consumption
This report provides analysis of the current regulatory framework in place in Israel for cannabis and cannabinoids, including CBD and hemp. It covers everything from cultivation and processing to finished products, extracts and import/export…
A British American Tobacco (BAT) subsidiary is investing a further CAD124.6m (USD90.2m) in its strategic partnership with Canadian licensed cannabis producer Organigram
22nd Century reported decreased revenues for the third quarter of 2023 and blamed demand challenges in its hemp/cannabis product distribution business, although this still represents the biggest part of its net revenue
This report offers detailed analysis of the current regulatory framework in place in Spain for hemp, CBD and other cannabinoids, as well medical and recreational cannabis
A coalition of centre-right, liberal, and left-wing forces is the most likely to form a new government in Poland before the end of the year, following elections held on 15th October
Partisan gridlock continues to keep Congress from clarifying the regulatory framework for CBD. Even as the Biden administration moves to reschedule cannabis, Congress punts CBD issues back and forth with the FDA
The nearly 18m people of the Netherlands face uncertainty following the collapse of the government this summer. The Cabinet is currently overseeing the nation with a “caretaker” status until the 22nd November general election
This report offers detailed analysis of the current regulatory framework in place in Thailand for cannabis and cannabinoids, including CBD and hemp. It covers everything from cultivation and processing to finished products, extracts and import/export
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
